Cristina Muñoz-Pinedo

Dr. Cristina Muñoz-Pinedo

IDIBELL - Bellvitge Biomedical Research Institute
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2018 in Cell Death & Differentiation
Verified
Journal Article
Open access
Lorenzo GalluzziLorenzo Galluzzi
Lorenzo Galluzzi
IVIlio Vitale
Ilio Vitale
SAStuart A. Aaronson
Stuart A. Aaronson
JAJohn M. Abrams
John M. Abrams
DADieter Adam
Dieter Adam
Guido KroemerGuido Kroemer
Guido Kroemer
Over the past decade, the Nomenclature Committee on Cell Death (NCCD) has formulated guidelines for the definition and interpretation of cell death from morphological, biochemical, and functional perspectives. Since the field continues to expand and novel mechanisms that orchestrate multiple cell death pathways are unveiled, we propose an updated classification of cell death subroutines focusing on mechanistic and essential (as opposed to correlative and dispensable) aspects of the process. As we provide molecularly oriented definitions of terms including intrinsic apoptosis, extrinsic apoptosis, mitochondrial permeability transition (MPT)-driven necrosis, necroptosis, ferroptosis, pyroptosis, parthanatos, entotic cell death, NETotic cell death, lysosome-dependent cell death, autophagy-dependent cell death, immunogenic cell death, cellular senescence, and mitotic catastrophe, we discuss the utility of neologisms that refer to highly specialized instances of these processes. The mission of the NCCD is to provide a widely accepted nomenclature on cell death in support of the continued development of the field.

19 December 2015 in The FEBS Journal
Verified
Journal Article
Closed access
PDF file
RIRaffaella Iurlaro
Raffaella Iurlaro
Cristina Muñoz-PinedoCristina Muñoz-Pinedo
Cristina Muñoz-Pinedo

20 July 2018 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
AAAitor Almanza
Aitor Almanza
ACAntonio Carlesso
Antonio Carlesso
CCChetan Chintha
Chetan Chintha
SCStuart Creedican
Stuart Creedican
DDDimitrios Doultsinos
Dimitrios Doultsinos
Afshin SamaliAfshin Samali
Afshin Samali
The endoplasmic reticulum (ER) is a membranous intracellular organelle and the first compartment of the secretory pathway. As such, the ER contributes to the production and folding of approximately one‐third of cellular proteins, and is thus inextricably linked to the maintenance of cellular homeostasis and the fine balance between health and disease. Specific ER stress signalling pathways, collectively known as the unfolded protein response (UPR), are required for maintaining ER homeostasis. The UPR is triggered when ER protein folding capacity is overwhelmed by cellular demand and the UPR initially aims to restore ER homeostasis and normal cellular functions. However, if this fails, then the UPR triggers cell death. In this review, we provide a UPR signalling‐centric view of ER functions, from the ER's discovery to the latest advancements in the understanding of ER and UPR biology. Our review provides a synthesis of intracellular ER signalling revolving around proteostasis and the UPR, its impact on other organelles and cellular behaviour, its multifaceted and dynamic response to stress and its role in physiology, before finally exploring the potential exploitation of this knowledge to tackle unresolved biological questions and address unmet biomedical needs. Thus, we provide an integrated and global view of existing literature on ER signalling pathways and their use for therapeutic purposes.

19 September 2014 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
Lorenzo GalluzziLorenzo Galluzzi
Lorenzo Galluzzi
José Manuel Bravo San PedroJosé Manuel Bravo San Pedro
José Manuel Bravo San Pedro
IVIlio Vitale
Ilio Vitale
SAS A Aaronson
S A Aaronson
JAJ M Abrams
J M Abrams
Guido KroemerGuido Kroemer
Guido Kroemer
Cells exposed to extreme physicochemical or mechanical stimuli die in an uncontrollable manner, as a result of their immediate structural breakdown. Such an unavoidable variant of cellular demise is generally referred to as ‘accidental cell death’ (ACD). In most settings, however, cell death is initiated by a genetically encoded apparatus, correlating with the fact that its course can be altered by pharmacologic or genetic interventions. ‘Regulated cell death’ (RCD) can occur as part of physiologic programs or can be activated once adaptive responses to perturbations of the extracellular or intracellular microenvironment fail. The biochemical phenomena that accompany RCD may be harnessed to classify it into a few subtypes, which often (but not always) exhibit stereotyped morphologic features. Nonetheless, efficiently inhibiting the processes that are commonly thought to cause RCD, such as the activation of executioner caspases in the course of apoptosis, does not exert true cytoprotective effects in the mammalian system, but simply alters the kinetics of cellular demise as it shifts its morphologic and biochemical correlates. Conversely, bona fide cytoprotection can be achieved by inhibiting the transduction of lethal signals in the early phases of the process, when adaptive responses are still operational. Thus, the mechanisms that truly execute RCD may be less understood, less inhibitable and perhaps more homogeneous than previously thought. Here, the Nomenclature Committee on Cell Death formulates a set of recommendations to help scientists and researchers to discriminate between essential and accessory aspects of cell death.

1 June 2004 in Cell
Verified
Journal Article
Closed access
JRJean-Ehrland Ricci
Jean-Ehrland Ricci
Cristina Muñoz-PinedoCristina Muñoz-Pinedo
Cristina Muñoz-Pinedo
PFPatrick Fitzgerald
Patrick Fitzgerald
BBBéatrice Bailly-Maitre
Béatrice Bailly-Maitre
GPGuy A Perkins
Guy A Perkins
DGDouglas R Green
Douglas R Green

26 April 2023 in Cell Death & Differentiation
Verified
Journal Article
Closed access
IVIlio Vitale
Ilio Vitale
FPFederico Pietrocola
Federico Pietrocola
EGEmma Guilbaud
Emma Guilbaud
SAStuart A. Aaronson
Stuart A. Aaronson
JAJohn M. Abrams
John M. Abrams
Lorenzo GalluzziLorenzo Galluzzi
Lorenzo Galluzzi